BioTuesdays

Tag - Jason Mills

Profound Medical

Canaccord ups Profound Medical PT to $20 from $14

Canaccord Genuity raised its price target for Profound Medical (NASDAQ:PROF; TSX:PRN) to $20 from $14 after the company announced preliminary Q4-2019 results. Shares of Profound were quoted at $14.72, up $1.73, or 13%...

Subscribe

Sign up to our weekly BioTuesdays newsletter.